Acetamide 250
MICRO LABS - 10 S
Standard delivery
₹43
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Medicines with the same active ingredient and strength as Avozosin-T 2.5MG Tab.
You are viewing
Avozosin-T 2.5MG Tab
tablet - 2.5 mg - 10 S
₹341
₹34.10 per tablet
GLENMARK PHARMACEUTICALS · tablet - 10 S · Rx
₹226
₹22.59 per tablet
Tofacitinib 2.5 mg (as tofacitinib citrate)
Treatment of autoimmune inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis and ulcerative colitis (as prescribed by specialist); may also be used for other immune-mediated diseases per doctor’s advice
Tofacitinib is a Janus kinase (JAK) inhibitor. It blocks JAK1/JAK3 signaling pathways involved in cytokine activity, thereby reducing immune overactivity, inflammation, pain and tissue damage.
Tablet for oral use. Take exactly as prescribed, at the same time each day, with or without food. Do not stop abruptly without medical advice; if you miss a dose, take it when remembered unless it is close to the next dose.
Common side effects of Avozosin-T 2.5MG Tab may include:
MICRO LABS - 10 S
Standard delivery
MICRO LABS - drop - 5 ml
Standard delivery
MICRO LABS - tablet - 15 S
Standard delivery
MICRO LABS - syrup - 60 ml
Standard delivery
MICRO LABS - 10 S
Standard delivery
MICRO LABS - tablet - 10 Tablet
Standard delivery
MICRO LABS - syrup - 60 ml
Standard delivery
MICRO LABS - tablet - 10 S
Standard delivery
A substitute contains the same active ingredient (salt), in the same strength, as Avozosin-T 2.5MG Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Prescription-only immunosuppressant. Increases risk of serious infections (TB, fungal, bacterial, viral); screening for TB/hepatitis may be required before and during therapy. Risk of herpes zoster, blood clots (DVT/PE), major cardiovascular events and certain malignancies may be increased in some patients; seek urgent care for chest pain, breathlessness, unilateral leg swelling, severe abdominal pain. Monitor CBC, liver function and lipids as advised; may cause low blood counts. Avoid live vaccines during treatment; keep vaccinations up to date prior to starting. Use caution in liver/kidney impairment; dose adjustments may be needed.